Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   Richard A. Larson   and   David Grinblatt.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.153
         
        
        
     
 
    
        
        - 
            Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803). Cancer. 2009 Jan 01; 115(1):84-93.
            
            
                Score: 0.078
            
         
        
        - 
            Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study. Cancer. 2025 Feb 15; 131(4):e35750.
            
            
                Score: 0.059
            
         
        
        - 
            Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study. Cancer Chemother Pharmacol. 2006 Jan; 57(2):199-206.
            
            
                Score: 0.015